Dr. Regina DePietro of MU Health Care says unapproved peptides sold for research lack the safety checks Ozempic went through, and suggests asking a doctor first.
Recap by typeshit. Full story at KCUR.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Bansal notes about 21% of US households now have a GLP-1 user, up from 9% in early 2025, and says India is watching the shift in fashion closely.
Novo Nordisk's pill form of Wegovy is now available to order through Amazon Pharmacy, per Polskie Radio. Details on pricing weren't included.
Loading…